Q3 2022 Holdings
Filed 2022-10-21 | 465 holdings | $46.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Taysha Gene Therapies Inc(TSHA) | Common Stock | 877619106 | $1 | 385 | 0.0% |
| Talaris Therapeutics Inc | Common Stock | 87410C104 | $1 | 391 | 0.0% |
| Passage BIO Inc | Common Stock | 702712100 | $1 | 510 | 0.0% |
| Surface Oncology Inc | Common Stock | 86877M209 | $1 | 544 | 0.0% |
| Black Diamond Therapeutics I(BDTX) | Common Stock | 09203E105 | $1 | 341 | 0.0% |
| Paratek Pharmaceuticals Inc | Common Stock | 699374302 | $1 | 514 | 0.0% |
| Spero Therapeutics Inc(SPRO) | Common Stock | 84833T103 | $1 | 329 | 0.0% |
| Candel Therapeutics Inc(CADL) | Common Stock | 137404109 | $1 | 271 | 0.0% |
| Spectrum Pharmaceuticals Inc | Common Stock | 84763A108 | $1 | 1,763 | 0.0% |
| Oyster Point Pharma Inc | Common Stock | 69242L106 | $1 | 251 | 0.0% |
| Ovid Therapeutics Inc(OVID) | Common Stock | 690469101 | $1 | 660 | 0.0% |
| Shattuck Labs Inc(STTK) | Common Stock | 82024L103 | $1 | 397 | 0.0% |
| Sesen BIO Inc | Common Stock | 817763105 | $1 | 1,868 | 0.0% |
| Achilles Therapeutics PL(698) | ADR | 00449L102 | $1 | 366 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | Common Stock | 00773U108 | $1 | 931 | 0.0% |
| Oric Pharmaceuticals Inc(ORIC) | Common Stock | 68622P109 | $1 | 370 | 0.0% |
| Athira Pharma Inc | Common Stock | 04746L104 | $1 | 354 | 0.0% |
| Autolus Therapeutics PLC(AUTL) | ADR | 05280R100 | $1 | 542 | 0.0% |
| Bolt Biotherapeutics Inc(BOLT1EUR) | Common Stock | 097702104 | $1 | 353 | 0.0% |
| Oncocyte Corp | Common Stock | 68235C107 | $1 | 1,111 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | Common Stock | 185063104 | $1 | 563 | 0.0% |
| Connect Biopharma Holdings L | ADR | 207523101 | $1 | 397 | 0.0% |
| Curis Inc(CRISEUR) | Common Stock | 231269200 | $1 | 860 | 0.0% |
| Cyteir Therapeutics Inc | Common Stock | 23284P103 | $1 | 332 | 0.0% |
| Rain Therapeutics Inc | Common Stock | 75082Q105 | $1 | 176 | 0.0% |
| Decibel Therapeutics Inc | Common Stock | 24343R106 | $1 | 233 | 0.0% |
| Olema Pharmaceuticals Inc(OLMA) | Common Stock | 68062P106 | $1 | 378 | 0.0% |
| Werewolf Therapeutics Inc(HOWL) | Common Stock | 95075A107 | $1 | 277 | 0.0% |
| Nextcure Inc | Common Stock | 65343E108 | $1 | 260 | 0.0% |
| Frequency Therapeutics Inc | Common Stock | 35803L108 | $1 | 330 | 0.0% |
| VOR Biopharma Inc | Common Stock | 929033108 | $1 | 356 | 0.0% |
| Puma Biotechnology Inc(PBYI) | Common Stock | 74587V107 | $1 | 426 | 0.0% |
| Harvard Bioscience Inc(HBIO) | Common Stock | 416906105 | $1 | 390 | 0.0% |
| Homology Medicines Inc | Common Stock | 438083107 | $1 | 538 | 0.0% |
| Icosavax Inc | Common Stock | 45114M109 | $1 | 373 | 0.0% |
| Ikena Oncology Inc | Common Stock | 45175G108 | $1 | 340 | 0.0% |
| Gamida Cell LTD | Common Stock | M47364100 | $1 | 561 | 0.0% |
| Compugen LTD(CGEN) | Common Stock | M25722105 | $1 | 811 | 0.0% |
| Proqr Therapeutics NV | Common Stock | N71542109 | $1 | 701 | 0.0% |
| Urogen Pharma LTD(URGN) | Common Stock | M96088105 | $2 | 213 | 0.0% |
| AC Immune SA(ACIU) | Common Stock | H00263105 | $2 | 783 | 0.0% |
| Xeris Biopharma Holdings Inc(XERS) | Common Stock | 98422E103 | $2 | 1,273 | 0.0% |
| Kamada LTD(KMDA) | Common Stock | M6240T109 | $2 | 419 | 0.0% |
| Kronos BIO Inc(KRON1USD) | Common Stock | 50107A104 | $2 | 532 | 0.0% |
| Kempharm Inc(ZVRA) | Common Stock | 488445206 | $2 | 323 | 0.0% |
| Omeros Corp(OMER) | Common Stock | 682143102 | $2 | 588 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | Common Stock | 56854Q200 | $2 | 349 | 0.0% |
| Macrogenics Inc(MGNX) | Common Stock | 556099109 | $2 | 575 | 0.0% |
| 89Bio Inc(ETNBGBP) | Common Stock | 282559103 | $2 | 366 | 0.0% |
| Rani Therapeutics Holdings(RANI) | Common Stock | 753018100 | $2 | 229 | 0.0% |